why choose us

First received: April 21, 2023

Clinical Trial: A Study of Doxycycline to Treat Chlamydial Infection

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Chlamydial Infection

Study Type: INTERVENTIONAL


Official Title: A Phase 4 Study of a 3-Day vs. 7-Day Regimen of Doxycycline for the Treatment of Chlamydial Infection

Brief Summary: This is a Phase 4 blinded, randomized, active-controlled, non-inferiority trial.Final evaluable population will include a minimum 596 individuals: 298 women with confirmed urogenital chlamydia (CT) and 298 men with confirmed rectal chlamydia (CT).Approximately 664 participants will be enrolled to achieve a minimum 596 participants who contribute primary outcome data.Randomization will be stratified by study site and sex: 332 women and 332 men.Participants will be randomized 1:1 to a 3-day regimen of doxycycline or…

Read more